Baxter (BAX) Tops Q1 EPS by 4c, Beats on Revenue; Offers FY26 EPS Guidance

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/8/2026

1. SPCX
2. SBUX
3. LEVI
4. NVDA
5. GOOGL
6. ORCL
7. USO
8. STZ
9. AAPL
10. SPY

Go back to Baxter (BAX) Tops Q1 EPS by 4c, Beats on Revenue; Offers FY26 EPS Guidance

Baxter Reports First-Quarter 2026 Results

April 30, 2026 7:15 AM EDT

Sales from continuing operations of $2.7 billion increased 3% on a reported basis and declined 1% on an organic basis1,2 U.S. GAAP3 diluted earnings per share (EPS) (loss) from continuing operations of ($0.03); adjusted diluted EPS from continuing operations of $0.36 Reiterates full-year 2026 financial outlook

DEERFIELD, Ill.--(BUSINESS WIRE)-- Baxter International Inc. (NYSE: BAX), a global medtech leader, today reported results for the first quarter of 2026.

Financial results for the quarter overall were in line with our expectations, and we are making progress to stabilize the... More